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Abstract: Certain strains of cyanobacteria produce a wide array of cyanotoxins, such as microcystins,
lyngbyatoxins and aplysiatoxins, that are associated with public health issues. In this pilot study,
an approach combining LC-MS/MS and molecular networking was employed as a rapid analytical
method to detect aplysiatoxins present in four environmental marine cyanobacterial samples collected
from intertidal areas in Singapore. Based on 16S-ITS rRNA gene sequences, these filamentous
cyanobacterial samples collected from Pulau Hantu were determined as Trichodesmium erythraeum,
Oscillatoria sp. PAB-2 and Okeania sp. PNG05-4. Organic extracts were prepared and analyzed
on LC-HRMS/MS and Global Natural Product Social Molecular Networking (GNPS) for the
presence of aplysiatoxin-related molecules. From the molecular networking, six known compounds,
debromoaplysiatoxin (1), anhydrodebromoaplysiatoxin (2), 3-methoxydebromoaplysiatoxin (3),
aplysiatoxin (4), oscillatoxin A (5) and 31-noroscillatoxin B (6), as well as potential new analogues,
were detected in these samples. In addition, differences and similarities in molecular networking
clusters related to the aplysiatoxin molecular family were observed in extracts of Trichodesmium
erythraeum collected from two different locations and from different cyanobacterial species found at
Pulau Hantu, respectively.
Keywords: filamentous marine cyanobacteria; aplysiatoxin; molecular networking; Trichodesmium
erythraeum; Okeania sp.; Oscillatoria sp.
1. Introduction
Marine filamentous cyanobacteria are prolific sources of novel secondary metabolites, and a
number of these compounds possess significant biological activity, having agricultural and
pharmaceutical applications [1,2]. A notable example is a series of highly cytotoxic lead compounds
belonging to the dolastatin class of molecules [3]. For instance, dolastatin 10 and synthetic derivatives,
soblidotin (TZT-1027) and tasidotin, entered clinical trials in the 1990s as anticancer agents but dropped
out in Phase II due to toxicity and/or lack of efficacy in trials [4]. A synthetic analogue, monomethyl
auristatin E, was subsequently formulated as an antibody-drug conjugate, brentuximab vendotin
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(Adecetris®), for the treatment of Hodgkin’s lymphoma and systemic anaplastic large cell lymphoma
in 2012 [5].
In recent years, various studies revealed that certain marine cyanobacterial strains produce
compounds that concurrently provide beneficial and detrimental effects to human health. One such
compound is the polyketide-based cyanotoxin, aplysiatoxin. Cyanotoxins collectively cause a wide
spectrum of health conditions, ranging from dermatitis to severe carcinoma [6–8]. Aplysiatoxin and
its related compounds, which includes oscillatoxin A and nhatrangins, have been reported from
Lyngbya majuscula, Oscillatoria nigro-viridis and Trichodesmium erythraeum [6]. The tumor promoting
activity of aplysiatoxin and debromoaplysiatoxin is attributed to their specific molecular roles as protein
kinase C activators. Interestingly, a simplified synthetic analogue of aplysiatoxin, aplog-1, was recently
reported to possess anti-cancer properties with mode of action similar to bryostatin 1 [9–13]. In addition,
studies revealed several aplysiatoxin-related compounds to display therapeutic activities, such as
anti-Chikungunya and modulation of potassium ion channels [14,15]. A recent study by Richard et al.
demonstrated that aplysiatoxin and its debrominated analogue induced expression of latent HIV-1
provirus in both cell line and primary cell models [16].
Due to the varied biological activities of the aplysiatoxins, they make good candidates for
biomedical research as well as in their detection and monitoring of toxins during algal bloom
occurrence. Given the correlation between global warming and occurrence of cyanobacterial
blooms, the incidence of illness caused by contact with cyanotoxins can potentially be increased [8].
In contrast to research on hepatotoxins (e.g., microcystins and nodularin) as well as other neurotoxins
(e.g., β-N-methylamino-l-alanine), very little work has been conducted on the development of
detection methods of other cyanotoxins, such as the aplysiatoxins [17]. In this report, we employed
MS/MS-based molecular networking approach for the rapid detection of aplysiatoxin class of
molecules from environmental marine cyanobacterial samples obtained from four intertidal areas in
Singapore. The detection method, based on either HPLC-HRMS/MS or UPLC-HRMS/MS combined
with data analysis using Global Natural Product Social Molecular Networking (GNPS), led to the
detection of both known and new analogues related to the aplysiatoxin class of cyanotoxins.
2. Results
2.1. Phylogenetic Analysis of Environmental Marine Cyanobacterial Samples
Of the four marine cyanobacterial samples analyzed in this study, three samples were collected
between June and August 2016 at three intertidal areas located at Pulau Hantu Besar (TLT/PHB/001),
Pulau Hantu Central Lagoon area 1 (TLT/PHC/001) and Pulau Hantu Central Lagoon area 2
(TLT/PHC/002). A fourth cyanobacterial sample, Trichodesmium erythraeum, was previously collected
from Pulau Seringat Kias (TLT/PSK/001) in August 2012 [8]. A phylogenetic tree comprising of
the three cyanobacterial samples from Pulau Hantu was constructed against seven cyanobacterial
strains and is presented in Figure 1. Gene sequence data, obtained after amplification of the 16S rRNA
gene, for TLT/PHB/001, TLT/PHC/001 and TLT/PHC/002 was assigned to Trichodesmium erythraeum
with a 97.8% sequence identity (1465 bp, 100% gene sequence coverage), Okeania sp. PNG05-4 with a
98.8% sequence identity (1399 bp, 95.8% gene sequence coverage), and Oscillatoria sp. PAB-21 with
a 99.1% sequence identity (1363 bp, 93.4% gene sequence coverage), respectively. Individual score
and coverage/identity giving corresponding closest homologs based on 16S-ITS rRNA sequences
from TLT/PHB, TLT/PHC001 and TLT/PHC002 were tabulated in Table S1 (Supplementary Data),
and complete 16S rRNA sequence in Table S2 (Supplementary Data).
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Figure 1. Phylogenetic tree ( axi u likelihood) for three environmental marine cyanobacterial
strains, TLT/P B/001, TLT/PHC/001 and TLT/PHC/002. The scale bar indicates 0.005 expected
nucleotide substit tio s er site.
2.2. MS/MS-Based Molecular Networks of Marine Cyanobacterial Extracts
Organic crude extracts from each of the cyanobacterial samples were prepared and analyzed
initially by UPLC–HRMS/MS Waters system (Milford, MA, USA). In addition, organic crude
extract from TLT/PSK/001 were analyzed on both HPLC-HRMS/MS Thermo–Finnigan system
(Waltham, MA, S ) (TLT/PSK/001a) and UPLC-HR S/MS Waters system (TLT/PSK/001b).
Mass spectrometric data obtained from these analyses were then used t generate molecular
networking clusters usi g the nline platform Global Natural Products Social Molecular Networking
(GNPS). Debromoaplysiatoxin (1) (Figure 2), is lated from the extract of TLT/PHC/001, was used
as se d molecule in the analysis (HRESIMS of sodiated mo ecular ion m/z 615.3005, a culated for
C32 48 10Na+ 615.2987, diff rence = 2.9 ppm). Molecular networks of the extracts (an example
is shown for LT/PHB/001 in Figure 3), vis alized using the softwar Cytoscape v3.5.1 (The
Cytoscape Consortium, New York, NY, USA), revealed the presence of clusters related to the molecular
family of the aplysiatoxin class in all four environmental cyanobacterial samples (clusters A to E in
Figure 4). In addition to the presence of the seeded debromoaplysiatoxin, five other related compounds
(Figure 2), namely, anhydrodebromoaplysiatoxin (2), 3-methoxydebromoaplysiatoxin (3), aplysiatoxin
(4), oscillatoxin A (5) and 31-noroscillatoxin B (6), were detected in clusters A, B, C and E based on
their HRMS (High-Resolution Mass Spectrometry) data (Table 1 and Figure 4). Furthermore, potential
new aplysiatoxin analogues, based on their relatedness to 1, were detected from the clusters. These
potential new compounds are indicated as 15 nodes from cluster A, eight nodes from both cluster B
and C, seven nodes from cluster D and 17 nodes from cluster E (Figure 4). Some putative assignments
for the new aplysiatoxin analogues were included, based on the HRMS m/z values.
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Figure 4. Cyanobacterial molecular network clusters based on the seeded 1 (nodes outlined)
with a cosine similarity cutoff of 0.65 obtained from extracts. (A): TLT/PHB/001 (square nodes),
(B): TLT/PHC/001 (diamond nodes), (C): TLT/PHC/002 (V-shape nodes), (D): TLT/PSK/001a (ellipse
nodes; based on Thermo–Finnigan system) and (E): TLT/PSK/001b (ellipse nodes; based on Waters
system). Italicized labels indicate putative assignments; numbers in bold indicate compounds 1 to 6
(refer to Figure 2). Edge thickness corresponds to elativ c sine similarity between nodes.
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Table 1. Mass differences (∆) of observed and calculated m/z values of known compounds found in
clusters, based on HRMS data obtained from Waters system.
Cluster Compound Molecular Formula ofObserved [M + Na]+ Calculated m/z Observed m/z
a∆ (ppm)
A
1 C32H48O10Na 615.2987 615.2988 +0.1
2 C32H46O9Na 597.3040 597.3047 +1.1
3 C33H50O10Na 629.3302 629.3308 +0.9
4 C32H47O10BrNa 695.2236 695.2227 −0.4
5 C31H46O10Na 601.2989 601.2982 −1.2
B
1 C32H48O10Na 615.2987 615.3005 +2.9
2 C32H46O9Na 597.3040 597.3024 −2.7
3 C33H50O10Na 629.3302 629.3307 +0.8
C
1 C32H48O10Na 615.2987 615.2986 −0.1
2 C32H46O9Na 597.3040 597.3058 +3.0
3 C33H50O10Na 629.3302 629.3290 −1.9
E
1 C32H48O10Na 615.2987 615.2985 −0.3
2 C32H46O9Na 597.3040 597.3027 −2.1
3 C33H50O10Na 629.3302 629.3308 +0.9
6 C31H44O10Na 599.2832 599.2843 +1.8
a∆ = Observed m/z − Calculated m/z.
3. Discussion
Certain cyanobacteria strains are known to produce a wide array of toxic metabolites or
cyanotoxins, such as aplysiatoxins, microcystins and nodularins [7]. Many of these cyanotoxins
affect human health through their actions as tumor promoters, diarrhetic, and pro-inflammatory
activities [18]. In addition, these metabolites may also limit various aquatic recreational activities,
thereby affecting related economies. Such impacts are particularly acute in certain geographical
regions, such as Singapore, where its location in the tropics provides a conducive environment for
the occurrence, growth, and more importantly blooms of marine cyanobacteria [19]. For instance,
regular occurrence of marine cyanobacterial blooms has been sighted at several offshore islands in
Singapore, including Pulau Semakau, P. Seringat-Kias, P. Hantu, P. Ubin and P. Sakijang Bendera.
The cyanobacterial samples used in this study were obtained from islands designated as tourist
destinations with aquatic recreational activities, including SCUBA diving and swimming, as the main
attraction. The persistent occurrence of marine cyanobacteria at these islands (personal observation
by Lik Tong Tan) warrants setting up of a rapid and relatively straightforward analytical method for
the detection of cyanotoxins from environmental samples. A rapid detection method is integral and
equally imperative to prevent the general public’s exposure to these toxic compounds.
In this study, molecular networking clusters of various environmental marine cyanobacterial
extracts were analyzed using a MS/MS-based molecular networking approach [20]. Initial chemical
investigation of the organic extract obtained from the cyanobacterial sample TLT/PHC/001 collected at
Pulau Hantu resulted in the isolation of the known cyanotoxin debromoaplysiatoxin (1). This molecule
was subsequently used as a seed molecule for the creation of the aplysiatoxin molecular family in the
molecular network. Each node within the clusters represent an ionized compound and dereplication
was performed by comparison with the m/z values of known aplysiatoxin-related analogues (Table 2).
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Table 2. A list of known aplysiatoxin and related analogues isolated from marine cyanobacteria with
the m/z values of commonly occurring proton and sodium adducts [1,7,14–16].
Compound MolecularFormula
Molecular
Mass
Calculated m/z
[M + H]+
Calculated m/z
[M + Na]+
Aplysiatoxin C32H47O10Br 671.621 672.622 694.604
Debromoaplysiatoxin C32H48O10 592.725 593.727 615.709
Oscillatoxin A C31H46O10 578.698 579.700 601.682
Anhydro-19-bromoaplysiatoxin C32H44O9Br2 732.502 733.502 755.484
Anhydro-19,21-dibromoaplysiatoxin C32H43O9Br3 811.398 812.398 834.380
17-Bromooscillatoxin A C31H45O10Br 657.594 658.595 680.577
17,19-Dibromooscillatoxin A C31H44O10Br2 736.491 737.491 759.473
19-Bromoaplysiatoxin C32H46O10Br2 750.517 751.518 773.500
Oscillatoxin B1 C32H46O10 590.709 591.711 613.692
Oscillatoxin B2 C32H46O10 590.709 591.711 613.692
31-Noroscillatoxin B C31H44O10 576.683 577.684 599.666
Oscillatoxin D C31H42O8 542.668 543.670 565.651
3-Methoxyaplysiatoxin C33H49O10Br 685.641 686.648 709.639
3-Methoxydebromoaplysiatoxin C32H46O10 606.745 607.753 629.735
Nhatrangin A C21H32O8 412.474 413.482 435.465
Nhatrangin B C21H31O8Br 491.370 492.378 514.360
Anhydrodebromoaplysiatoxin C32H46O9 574.702 575.711 597.693
30-Methyloscillatoxin D C32H44O8 556.695 557.696 579.678
Manauealide A C32H47O10Cl 627.168 628.171 650.153
Manauealide B C32H47O10Br 671.621 672.622 694.604
Manauealide C C34H50O11 634.762 635.763 657.745
Anhydrooscillatoxin A C31H44O9 560.683 561.685 583.667
Anhydroaplysiatoxin C32H45O9Br 653.606 654.607 676.589
Neo-debromoaplysiatoxin A C32H46O10 590.703 591.712 613.693
Neo-debromoaplysiatoxin B C27H38O6 458.588 459.596 481.578
In addition to debromoaplysiatoxin, a number of known analogues, anhydrodebromoaplysiatoxin
(2), 3-methoxydebromoaplysiatoxin (3), aplysiatoxin (4), oscillatoxin A (5) and 31-noroscillatoxin B
(6), were found to be present in the molecular network clusters A, B, C and E. The identity of these
known compounds was confirmed by comparing the calculated m/z values with that obtained from
HRMS/MS (differences of less than 5 ppm) as shown in Tables 1 and 2. Compounds 1–3 were present
in clusters A, B, C and E. Additional compounds 4 and 5 were also present in cluster A while 6 was
found in cluster E.
The phylogenetic results of the cyanobacterial samples, coupled with careful analysis of the
molecular networking clusters of their extracts, revealed a number of interesting observations. Though
both TLT/PHB/001 and TLT/PSK/001 cyanobacterial samples have been identified as Trichodesmium
erythraeum, their clusters (A and E), related to the aplysiatoxin molecular family based on the seeded
1, were different (Figure 4). Clusters A and E gave 15 and 17 nodes, respectively, both revealing the
presence of all three compounds 1–3. The difference in the complexity of these two Trichodesmium
erythraeum-derived molecular network clusters and the number of nodes present may be attributed
to the versatility of the biosynthetic gene clusters present in the same cyanobacteria, and different
environmental triggers present in the two locations where the cyanobacteria were collected. On the
other hand, aplysiatoxin-related clusters B and C produced from two different cyanobacterial species,
TLT/PHC/001 (identified as Okeania sp. PNG05-4) and TLT/PHC/002 (identified as Oscillatoria
sp. PAB-21), respectively, with only slight difference in the m/z (within 5 ppm) observed between
corresponding nodes. Interestingly, these two samples were collected from sites that were just
100 m apart at Pulau Hantu. In addition, when comparing the full molecular networks of these
two different cyanobacterial species (Figure 5), minimal differences in the compounds, aside from the
aplysiatoxin-related cluster, were observed. These observations suggest that similar compounds are
largely produced as a result of the same environmental triggers, though by different cyanobacteria, and
this can be validated with the help of results obtained through the investigations of related biosynthetic
gene clusters of TLT/PHC/001 and TLT/PHC/002 in producing the aplysiatoxin-related compounds.
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It has been shown that the MS/MS-based molecular networking is useful for dereplication of
known compounds as well as the discovery of potentially new natural products [21]. In molecular
networking, MS/MS spectra are compared based on the similarity and differences in fragmentation
patterns. Structurally related compounds can then be clustered as nodes due to certain degrees
of similarity between the compounds expressed as edges in the molecular network. In addition,
the availability of HRMS/MS spectral data of known cyanotoxins in GNPS database could facilitate the
detection process [22]. Recently, Teta and co-workers used a similar MS-based molecular networking
approach to detect new microcystin variants from the 2014 freshwater cyanobacterial harmful bloom
at Green Lake, Seattle [23]. In another study by Briand et al., molecular networking was employed to
track changes in secondary metabolic profiles, including microcystins and other peptides, of Microcystis
aeruginosa strains due to intraspecific interactions [24]. In this present study, two nodes with m/z
629.219 and 629.220 observed in clusters B, C and E are likely to be compound 3. However, it is evident
that only the node with observed value of 629.22 fits within the accepted ppm difference for compound
3 (Figure 4). Considering the presence of both nodes found within the same cluster, the node of m/z
629.219 could be a new analogue related to 2. A similar relationship was observed from the nodes of
m/z 615.218 and 615.298 present in the same set of clusters (Figure 4). Some putative assignments
were provided to unknown compounds based on observed HRMS of the nodes within each cluster.
An example is the compound with m/z value of 631.247 in clusters B and C that could correspond
to an analogue of 3 having a reduced carbonyl moiety or cleavage to the oxide functionality of either
tetrahydropyran rings.
The advantages of use and advancements in instrumentation provided a variety of MS/MS
systems used by laboratories today. An interesting technical approach adopted in this study was to
employ two different systems in the analysis, namely a low-resolution Thermo-Finnigan HPLC-MS/MS
and a high-resolution Waters UPLC-MS/MS. The main reason was to make comparisons of the
molecular networks created based on each system. The organic extract from TLT/PSK/001 was
randomly chosen and molecular networks were then constructed individually using the MS/MS
data acquired from both MS systems using similar parameters. Analysis of the molecular network
clusters TLT/PSK/001a (D) and TLT/PSK/001b (E) using Thermo–Finnigan and Waters systems,
respectively, revealed several differences. The first difference was the size of each molecular network
due to a difference in quantity of nodes present, with 7 and 17 nodes in clusters D and E, respectively.
Another difference was observed comparing compounds 1, 2 and 6 present in both clusters, where
each corresponding node in both clusters gave different m/z values. A case in point is the node that
corresponds to 2, with m/z of 597.267 and 597.261 observed in clusters D and E, respectively. The
chemical identity of the corresponding nodes was achieved and confirmed to be 2 in both clusters,
where a mass difference of within 5 ppm was determined based on the observed and calculated m/z
obtained from its respective system. The last difference was the detection of different compounds from
the same cyanobacterial strain in the two molecular networks. Compounds 4 and 5 were observed
exclusively in cluster D obtained from the Thermo–Finnigan system; compound 3 observed in cluster E
created using the Waters system. While the exact explanation could not be provided, these differences
between the clusters may be attributed largely to the different MS instruments’ operating parameters
(i.e., resolution, type of ionization and detector), hence care should be taken while comparing molecular
networks from different systems.
Current aquatic biomonitoring and ecotoxicology programs in Singapore are confined to the
analysis of freshwater cyanobacterial strains for hepatoxins, such as microcystins and nodularin.
Methods, such as mass spectrometry, capillary electrophoresis and qPCR, have been used for the
detection of microcystins as well as for assessing cyanotoxin risk in freshwater cyanobacterial
strains obtained from reservoirs in Singapore [25–27]. The unprecedented nature of this pilot study
underscores the importance of the MS/MS-based molecular networking approach as a rapid analytical
technique to detect non-peptidic cyanotoxins, such as the aplysiatoxins, from environmental samples.
Moreover, recent reports showed that several aplysiatoxin analogues possess therapeutic activities,
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such as antiviral and potassium channel inhibition activities [14,15]. In light of these discoveries,
the MS/MS-based molecular networking approach employed in this study could aid in the detection
of new aplysiatoxin analogues that harbors varied biomedical potential, contributing to the growing
list of marine natural products as therapeutic agents.
4. Materials and Methods
4.1. General Experimental Procedures
Proton NMR spectra were recorded in CDCl3 on a 400 MHz Bruker (Billerica, MA, USA)
NMR spectrometer using the residual solvent signals (δH at 7.28 ppm) as internal standards.
High-performance liquid chromatography isolation and purification of compound 1 was conducted on
a Shimadzu (Nakagyo-ku, Kyoto, Japan) LC-8A preparative LC coupled to a Shimadzu SPD-M10A VP
diode array detector. The UPLC-HRMS/MS analysis was conducted on a Waters (Milford, MA, USA)
Xevo G2-XS qTOF with an ESI positive ion mode and data-dependent acquisition mode to obtain MS
and MS/MS data. The HPLC-MS/MS analysis was conducted on a Thermo–Finnigan (San Jose, CA,
USA) LCQ Advantage ion trap mass spectrometer with an ESI positive ion mode and data-dependent
manner to obtain MS and MS/MS data. High-performance liquid chromatography preparative and
analytical columns was obtained from Phenomenex (Torrance, CA, USA), and a UPLC analytical
column was obtained from Waters. All solvents were HPLC-grade purchased from Thermo-Fisher
Scientific (Waltham, MA, USA) and HPLC-grade water obtained by filtration using a Milli-Q Direct
water purification system from Millipore (Billerica, MA, USA) unless otherwise stated. Deuterated
NMR solvents were purchased from Cambridge Isotope Laboratories (Tewksbury, MA, USA).
4.2. Marine Cyanobacterial Collections
Samples of the benthic filamentous marine cyanobacteria were collected from offshore islands
of Pulau Seringat Kias on August 7, 2012 (TLT/PSK/001), Pulau Hantu Besar, on 9 June 2016
(TLT/PHB/001), and Pulau Hantu Central Lagoon area 1 on 6 August 2016 (TLT/PHC/001) and Pulau
Hantu Central Lagoon area 2 on 9 June 2016 (TLT/PHC/002). Voucher samples are stored at Natural
Products Chemistry Laboratory, National Institute of Education, Nanyang Technological University,
Singapore as TLT/PSK/07AUG2012/001, TLT/PHB/09JUNE2016/001, TLT/PHC/06AUG2016/001
and TLT/PHC/09JUNE2016/002, respectively. A small amount of the cyanobacterial samples collected
in 2016 (TLT/PHB/001, TLT/PHC/001 and TLT/PHC/002) was preserved for genetic analysis in
RNAlater® (Ambion, Austin, TX, USA). Chemistry samples were preserved in 70% aqueous EtOH at
−20 ◦C before chemical extraction.
4.3. DNA Isolation and PCR Amplification
Genetically preserved biomass (~ 150 mg) of each of the three filamentous marine cyanobacteria
samples were washed 3 times with 3M NaCl solution. Genomic DNA was extracted using
CTAB procedure as described previously, with increased lysozyme concentration of 5 mg/mL.
The 16S rRNA genes and the 16S-23S ITS regions were PCR-amplified using primers 27F
(5′-AGAGTTTGATCMTGGCTCAG-3′) and 340 (5′-CTCTGTGTGCCTAGGTATCC-3′) [28,29]. The PCR
reaction volumes were 25 µL containing: 1 µL (~100 ng) of DNA, 5 µL of 5×Q5 reaction buffer, 0.5 µL of
(10 mM) dNTP mix, 1.25 µL of each primer (10 µM), 0.25 µL of Q5 High-Fidelity DNA polymerase and
15.75 µL of dH2O. The PCR reactions were performed in a T100TM Thermal Cycler (Bio-Rad, Hercules,
CA, USA) using the following program: Initial denaturation for 30 s at 98
◦
C, amplification by 30 cycles
of 10 s at 98 ◦C, 15 s at 63 ◦C and 2 min at 72 ◦C, and final elongation for 10 min at 72 ◦C. The PCR
products were analyzed on 1% agarose gel in TAE (Tris-acetate-EDTA) buffer and visualized by gel
red. The PCR products were purified using NucleoSpin Gel and PCR Clean-up kit (Macherey-Nagel,
Duren, Germany). All purified PCR products of 27F and 340 primers were sequenced with 883R
primer (5′-ATTAAACCACATACTCCACC-3′), FR primer (5′-ACGAGCTGACGACAGCCATG-3′), HR
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primer (5′-AAGGAGGTGATCCAGCCGCA-3′) and 1052F (5′-CATCATTAAGTTGGGCACTC-3′) [22].
Sequencing was performed at 1stBASE Laboratories Sdn BhD (Singapore).
4.4. Phylogenetic Analysis
Gene sequences were aligned using MUSCLE (European Bioinformatics Institute, EMBL-EBI,
Cambridge, United Kingdom) [30]. The phylogenetic tree was plotted using maximum likelihood
(ML) in MEGA, v6 (Pennsylvania State University, State College, PA, USA) [31]. The 16S rRNA
gene sequence of each cyanobacterial sample was multiply aligned with 7 cyanobacterial strains
obtained from the GenBank/EMBL/DDBJ databases. Bootstrap re-sampling was performed with
1000 replicates.
4.5. Extraction of Crude Extracts and Isolation of Debromoaplysiatoxin (1)
Each of the four environmental cyanobacterial samples (about 10 g each) were exhaustively
extracted with 2:1 CH2Cl2/MeOH. The crude extract from TLT/PHC/001 (1.421 g) was chosen and
dried under vacuum and applied to a silica gel VLC column. The column was eluted to produce
nine sub-fractions: C1 (elution by 100% hexanes), C2 (elution by 10% EtOAc/hexanes), C3 (elution
by 30% EtOAc/hexanes), C4 (elution by 50% EtOAc/hexanes), C5 (elution by 60% EtOAc/hexanes),
C6 (elution by 80% EtOAC/hexanes), C7 (elution by 100% EtOAc), C8 (elution by 10% MeOH/EtOAc)
and C9 (20% MeOH/EtOAc). Sub-fractions were subjected to Brine Shrimp Toxicity Assay and
sub-fraction C6 displayed mortality at 93.2% and 81.9% when tested at 100 ppm and 10 ppm,
respectively. The remaining sub-fraction C6 (121.4 mg) was filtered over a C18 SPE cartridge by elution
with 50% MeOH/H2O. The filtered sample (29.0 mg) was subjected to preparative reversed-phase
HPLC separation using a Phenomenex Luna phenyl-hexyl column (250 mm × 100 mm, 5 µm). Elution
at 3.0 mL/min using eluent A: H2O; eluent B: CH3CN; gradient: 38% B for 1.5 min, 38→80% B in
5.5 min, 80→100% B in 5 min, then held at 100% B for 18 min to yield 1 (8 mg, tR = 20.024 min).
Structure and identity of 1 was confirmed based on proton NMR in CDCl3 (Figure S1, Supplementary
Data) and HRESIMS m/z 615.3005 (calculated for C32H48O10Na+, 615.2987, difference = 2.9 ppm). Mass
spectrometry parameters included a spray voltage of 3 kV, cone voltage of 40 V, source temperature
of 120 ◦C, desolvation temperature of 450 ◦C, cone gas flow of 50 L/h and desolvation gas flow of
950 L/h.
4.6. UPLC-HRMS/MS Analysis
Crude extracts were re-dissolved in 1 mL CH3CN with vortex mixing over 5 min before
transferring into separate Eppendorf tubes. Tubes were then centrifuged at 10,000 rpm at 4 ◦C over
10 min and the supernatant was aliquoted and finally diluted with CH3CN to 10,000× dilution. Then,
1.5 µL of each 10,000× dilution sample was subjected to UPLC-HRMS/MS performed using the same
high-resolution spectrometer and parameters stated above, together with a Waters ACQUITY BEH
C1850 mm × 2.1 mm, 1.7 µm column and maintained at a column temperature of 40 ◦C and sample
temperature at 4 ◦C using a step elution program of ‘1’ based on the Waters system. Step elution
program was as follows: Mobile phase of 98% CH3CN in 0.1% aq. HCOOH/0.1% aq. HCOOH,
run time of 14 min and flow rate of 0.5 mL/min. All the mass spectra were recorded in the positive-ion
mode. Data were collected in the data-dependent acquisition mode, in which the first ten most intense
ions of a full-scan mass spectrum were subjected to MS/MS analysis. Tandem mass spectrometry
scans were obtained for selected ions with a mass range of 100–2000 Da, MS scan time of 0.33 s over
12 min, MS/MS scan time of 0.10 s and a collision energy ramp of 10–50 V.
4.7. HPLC-MS/MS Analysis
TLT/PSK/001 was re-dissolved in MeOH and 20 µL of the solution was subjected (no-waste
mode) to HPLC-MS/MS using a Thermos–Finnigan system with a Phenomenex Kinetex C 18 100 mm
× 4.6 mm, 5 µm column. Elution at 0.5 mL/min using eluent A: 0.1% aq. HCOOH in H2O; eluent B:
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CH3CN; gradient: 30→100% B over 20 min, then held at 100% B for 10 min. The HPLC eluate was
electrospray ionized at 35 eV and analyzed for positive ions, and MS/MS spectra were obtained in a
data-dependent manner using collision induced dissociation (CID) at 35 eV.
4.8. Molecular Networking Creation
The mass spectral data were converted to .mzXml format using the program msconvert
(ProteoWizard Software Foundation, Los Angeles, CA, USA). A molecular network was created
using the online workflow at GNPS website [32]. The data were filtered by removing all MS/MS
peaks within ± 17 Da of the precursor m/z. Tandem mass spectrometry spectra were window filtered
by choosing only the top 6 peaks in the ± 50 Da window throughout the spectrum. The data were
then clustered with MS-Cluster with a parent mass tolerance of 2.0 Da and a MS/MS fragment ion
tolerance of 0.5 Da to create consensus spectra. Further, consensus spectra that contained less than
2 spectra were discarded. A network was then created where edges were filtered to have a cosine
score above 0.65 and more than 10 matched peak. Further edges between two nodes were kept in the
network if, and only if, each of the nodes appeared in each other’s respective top 10 most similar nodes.
The spectra in the network were then searched against GNPS’ spectral libraries. The library spectra
were filtered in the same manner as the input data. The data were then imported into Cytoscape v3.5.1
(The Cytoscape Consortium, New York, NY, USA) and displayed as a network of nodes and edges [26].
All matches kept between network spectra and library spectra were required to have a score above
0.65 and at least 1 matched peak. Analogue search was enabled against the library with a maximum
mass shift of 100.0 Da.
Supplementary Materials: The following are available online at http://www.mdpi.com/1660-3397/16/12/505/
s1, 1H NMR of 1, and phylogenetic data of TLT/PHB/001, TLT/PHC/001 and TLT/PHC/002.
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